Leishmaniasis Global Clinical Trials Review H2 2017: Ken Research - PowerPoint PPT Presentation

Loading...

PPT – Leishmaniasis Global Clinical Trials Review H2 2017: Ken Research PowerPoint presentation | free to download - id: 892e56-NDU4M



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Leishmaniasis Global Clinical Trials Review H2 2017: Ken Research

Description:

This report provides top line data relating to the clinical trials on Leishmaniasis (Kala-Azar). To know more, click on the link below: – PowerPoint PPT presentation

Number of Views:23

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Leishmaniasis Global Clinical Trials Review H2 2017: Ken Research


1
Leishmaniasis Global Clinical Trials Review H2
2017 Ken Research
2
GlobalData'sclinical trial report, Leishmaniasis
(Kala-Azar) Global Clinical Trials Review, H2,
2017" provides an overview of Leishmaniasis
(Kala- Azar) clinical trials scenario. This
report provides top line data relating to the
clinical trials on Leishmaniasis (Kala- Azar).
Report includes an overview of trial numbers and
their average enrollment in top countries
conducted across the globe. The report offers
coverage of disease clinical trials by region,
country (G7 E7), phase, trial status, end
points status and sponsor type. Report also
provides prominent drugs for in-progress trials
(based on number of ongoing trials). Global Data
Clinical Trial Reports are generated using
GlobalData'sproprietary database- Pharma eTrack
Clinical trials database. Clinical trials are
collated from 80 different clinical trial
registries, conferences, journals, news etc
across the globe. Clinical trials database
undergoes periodic update by dynamic process.
3
The report enhances the decision making
capabilities and helps to create an effective
counter strategies to gain competitive
advantage. Note Certain sections in the report
may be removed or altered based on the
availability and relevance of data for the
indicated disease. Scope The report provides a
snapshot of the global clinical trials landscape
Report provides top level data related to the
clinical trials by Region, Country (G7 E7),
Trial Status, Trial Phase, Sponsor Type and End
point status The report reviews top companies
involved and enlists all trials (Trial title,
Phase, and Status) pertaining to the company The
report provides all the unaccomplished trials
(Terminated, Suspended and Withdrawn) with reason
for unaccomplishment the Report provides
enrollment trends for the past five years Report
provides latest news for the past three months
4
Note Certain sections in the report may be
removed or altered based on the availability and
relevance of data for the indicated disease. Key
Topics Covered in the Report Leishmaniasis
Global Clinical Trials Review H2 Global
Leishmaniasis Market Global Clinical Trials
Review H2 Global Leishmaniasis Market
Trends Global Leishmaniasis Market Size Global
Clinical Trials Industry Research Global
Leishmaniasis Clinical Trials Market
Analysis Global Clinical Trials Market
Forecast Global Leishmaniasis Market
Outlook Global Clinical Trials Market
Growth Global Clinical Trials Market Overview
5
To know more, click on the link
below https//www.kenresearch.com/healthcare/phar
maceuticals/leishmaniasis-kala-azar-global-clinica
l-trials/142636-91.html Related
reports https//www.kenresearch.com/healthcare/pha
rmaceuticals/leishmaniasis-kala-azar-pipeline/9925
-91.html https//www.kenresearch.com/healthcare/p
harmaceuticals/leishmaniasis-kala-azar-global-clin
ical/80190-91.html Contact Ken
Research Ankur Gupta, Head Marketing
Communications sales_at_kenresearch.com 91-124-42302
04
About PowerShow.com